- Redfund
Capital is focusing the power of its equity financing and debt financing
business incubation model toward flourishing cannabis industry startups
- The
company is labeling its recent investment in the international Cannabis
Mercantile Exchange (“Cannamerx”) auction platform as “one of our most strategic
growth alliances”
- Cannamerx
is gaining a growing clientele in the hemp and CBD industries, noting
recently that it had clients listing 1.5 metric tons of hemp biomass for
auction
- The
global hemp market is forecast to reach $5.7 billion in revenues by 2020
Enterprising Canadian finance firm Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt:
O3X4) is strengthening its business incubation model through equity
financing and debt financing in the emerging cannabis industries, announcing
recently that it will partner with the Cannabis Mercantile Exchange
(“Cannamerx”) as Cannamerx rolls out the first international global hemp and
cannabidiol (CBD) auction platform.
Redfund’s focus on accelerating revenue-producing companies
by helping them fund their efforts to get to the next level without giving away
equity prematurely has proven a natural fit for rising businesses in the
cannabis space as cannabis products gain new social and regulatory acceptance
worldwide.
Redfund Capital extended funds to three cannabis companies
during the year’s first quarter — RxMM Health, Mary’s Wellness Ltd. and
Winterlife Inc. — and it has established a new investment in Wahupta Ventures
Inc. (http://ibn.fm/qG3Ko),
as well as recent funding for the Cannaki Beverage Company (http://ibn.fm/9sgy2).
The Redfund-Cannamerx alliance announced on March 20 (http://ibn.fm/6uMSa) that it
will provide the fully automated business-to-business (B2B) international
auction platform with funding to establish its business model and build its
global footprint of clientele for wholesale cannabis and cannabis products. On
the heels of the announcement, the companies reported that they had listed 1.5
metric tons of hemp biomass for auction (http://ibn.fm/u22cV) on what the companies label “the first
international global Hemp/CBD auction platform” and the Midas Letter labels
a “B2B eBay” for the cannabis industry (http://ibn.fm/7iDBs).
Cannamerx is drawing hemp clients in Canada, the United
States and Europe and is in the process of seeking CBD labs in the United
States that it can work with for trade in that country.
“The hemp revolution has begun in North America,” Redfund
CEO Meris Kott stated in a news release. “We are excited to help Cannamerx
create a global path for many of these companies to trade Hemp/CBD
internationally and become cash flow positive at a much quicker pace,
decreasing their sales and marketing expenses and removing the ‘middleman’
thereby increasing net revenues. By next fall, we are hopeful CBD edibles will
be federally approved and licensed in Canada with Cannamerx’s platform providing
the raw materials to licensed LPs, who need hemp.”
Kott added, “Investing in a working cannabis auction
platform in the sector is a game-changer. Cannamerx has the ability to connect
European buyers with Canadian licensed sellers and South American licensed
producers can with a click of a mouse list their products placing reserve
prices to the rest of the world. There are many technology marketing plans to
connect the world but Cannamerx have already established themselves as the
go-to platform. Redfund recognizes that this is one of our most strategic
growth alliances.”
Kott added (http://ibn.fm/pzoaG)
that the company’s strategy is to develop a portfolio of 20 companies with $75
million in loans to businesses that have “commonalities of revenues, brand
awareness, and a keen interest to go global with their products.” This includes
a drive to diversify Redfund’s investments in Canada and other countries,
building an international footprint with established companies and introducing
companies to Canada as a viable location for public listings.
Redfund cites a New Frontier Data market forecast predicting
that the global hemp market will reach $5.7 billion in revenues by 2020,
attributing the growth mostly to Chinese textiles, European industrials,
Canadian foods and the hemp-derived CBD product market in the United States.
Drug store outlets Walgreens Boots Alliance Inc. (NASDAQ: WBA) and CVS Health
Corp. (NYSE: CVS) exemplify the market expectations, announcing during the
final week of the quarter that they will begin offering CBD products in select
states (http://ibn.fm/fAW25).
For more information, visit the company’s website at www.RedfundCapital.com
NOTE TO INVESTORS: The latest news and updates
relating to PNNRF are available in the company’s newsroom at http://ibn.fm/PNNRF
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment